Synthesis and Activity of 4,5-Diarylimidazoles as Human CB1 Receptor Inverse Agonists.
Christopher W. Plummer, et al. et al.Volume:
36
Year:
2005
Pages:
1
DOI:
10.1002/chin.200529225
File:
PDF, 11 KB
2005